Hawthorne Has Been Accused of Patent Infringement Over Generic Insomnia Drug

A Hawthorne pharmaceutical company that has applied for federal approval to produce a generic insomnia drug has been sued for patent infringement.

Currax Pharmaceuticals accused Taro Pharmaceuticals U.S.A. Inc. of ten counts of patent infringement, in a complaint filed on July 2 in U.S. District Court, White Plains.

Read More at Westfair Business Journal